Systemic Immune Response to Vaccination on FDG-PET/CT

被引：26
作者：
Mingos M. [1 ]
Howard S. [1 ]
Giacalone N. [2 ]
Kozono D. [2 ]
Jacene H. [1 ]
机构：
[1] Department of Imaging, Dana-Farber Cancer Institute and Department of Radiology, Brigham and Women’s Hospital, 450 Brookline Avenue, Boston, 02215, MA
[2] Department of Radiation Oncology, Brigham and Women’s Hospital, 75 Francis Street, Boston, 02115, MA
来源：
Nuclear Medicine and Molecular Imaging | 2016年 / 50卷 / 4期
关键词：
FDG; FDG-PET/CT; Immunization; Lung cancer; Spleen; Vaccine;
D O I：
10.1007/s13139-015-0385-6
中图分类号：
学科分类号：
摘要：
A patient with newly diagnosed right lung cancer had transient 18F-fluorodeoxyglucose (FDG)-avid left axillary lymph nodes and intense splenic FDG uptake on positron emission tomography (PET)/computed tomography (CT). History revealed that the patient received a left-sided influenza vaccine 2–3 days before the examination. Although inflammatory FDG uptake in ipsilateral axillary nodes is reported, to our knowledge, this is the first report of visualization of the systemic immune response in the spleen related to the influenza vaccination on FDG-PET/CT. The history, splenic uptake and time course on serial FDG-PET/CT helped to avoid a false-positive interpretation for progressing lung cancer and alteration of the radiation therapy plan. © 2015, Korean Society of Nuclear Medicine.
引用
收藏
页码：358 / 361
页数：3
相关论文
共 14 条
  • [1] Panagiotidis E., Exarhos D., Housianakou I., Et al., FDG uptake in axillary lymph nodes after vaccination against pandemic (H1N1), Eur Radiol, 20, pp. 1251-1253, (2010)
  • [2] Shirone N., Shinkai T., Yamane T., Et al., Axillary lymph node accumulation on FDG-PET/CT after influenza vaccination, Ann Nucl Med, 26, pp. 248-252, (2012)
  • [3] Thomassen A., Lerberg Nielsen A., Gerke O., Et al., Duration of 18 F-FDG avidity in lymph nodes after pandemic H1N1v and seasonal influenza vaccination, Eur J Nucl Med Mol Imaging, 38, pp. 894-898, (2011)
  • [4] Williams G., Joyce R.M., Parker J.A., False-positive axillary lymph node on FDG-PET/CT scan resulting from immunization, Clin Nucl Med, 31, pp. 731-732, (2006)
  • [5] Nam H.Y., Kim S.J., Kim I.J., Et al., The clinical implication and prediction of diffuse splenic FDG uptake during cancer surveillance, Clin Nucl Med, 35, pp. 759-763, (2010)
  • [6] Salaun P.Y., Gastinne T., Bodet-Milin C., Et al., Analysis of 18 F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin’s lymphoma: a reflection of disease infiltration or just inflammation?, Eur J Nucl Med Mol Imaging, 36, pp. 1813-1821, (2009)
  • [7] Basu S., Baghel N.S., Intense FDG uptake in the spleen due to recent granulocyte-macrophage colony-stimulating factor administration: follow-up scan clarifying the situation, J Cancer Res Ther, 7, pp. 228-229, (2011)
  • [8] Jacene H.A., Ishimori T., Engles J.M., Et al., Effects of pegfilgrastim on normal biodistribution of 18 F-FDG: preclinical and clinical studies, J Nucl Med, 47, pp. 950-956, (2006)
  • [9] Liu Y., Clinical significance of diffusely increased splenic uptake on FDG-PET, Nucl Med Commun, 30, pp. 763-769, (2009)
  • [10] Sugawara Y., Zasadny K.R., Kison P.V., Et al., Splenic fluorodeoxyglucose uptake increased by granulocyte colony-stimulating factor therapy: PET imaging results, J Nucl Med, 40, pp. 1456-1462, (1999)
12